Precision 360
Oncology Research Acceleration
CommercialPart of Precision Suite
Key Facts
Indication
Oncology Research Acceleration
Phase
Commercial
Status
Part of Precision Suite
Company
About ConcertAI
ConcertAI's mission is to accelerate insights and improve patient outcomes through its leading real-world data, AI technologies, and scientific expertise. The company has established a comprehensive platform integrating deep, multi-modal oncology data with generative and agentic AI solutions, serving major life science clients and healthcare providers. Backed by significant investment from groups like SymphonyAI and Sixth Street, ConcertAI is positioned as a key enabler of precision medicine and efficient drug development.
View full company profile